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868Objective: We sought to investigate the impact of 22q11.2 deletion on perioperative outcome in tetralogy of
Fallot.
Methods: We conducted a retrospective review of patients with tetralogy of Fallot who underwent complete
surgical reconstruction at The Children’s Hospital of Philadelphia between 1995 and 2006. Inclusion criteria
included diagnosis of tetralogy of Fallot and known genotype. Fisher exact and Mann–Whitney tests were
used for categoric and continuous variables, respectively. Regression analysis was used to determine whether
deletion status predicts outcome.
Results: We studied 208 subjects with tetralogy of Fallot, 164 (79%) without and 44 (20%) with 22q11.2 de-
letion syndrome. There were no differences in sex, race, gestational age, age at diagnosis, admission weight, and
duration of mechanical ventilation. Presenting anatomy, survival, complications and reoperations were also
comparable between patients with and without 22q11.2 deletion syndrome. Those with 22q11.2 deletion syn-
drome had more aortopulmonary shunts preceding complete surgical repair (21% vs 7%, P ¼ .02). This asso-
ciation was present after adjustment for presenting anatomy (stenosis, atresia, or absence of pulmonary valve
and common atrioventricular canal) and surgical era. In addition, those with 22q11.2 deletion syndrome had
longer cardiopulmonary bypass time (84 vs 72 minutes, P ¼ .02) and duration of intensive care (6 vs 4 days,
P ¼ .007).
Conclusions: Genotype affects early operative outcomes in tetralogy of Fallot resulting, in particular, in longer
duration of intensive care. Future studies are required to determine factors contributing to such differences in this
susceptible population. (J Thorac Cardiovasc Surg 2013;146:868-73)Tetralogy of Fallot (TOF) is the most common cyanotic
congenital heart disease, comprising up to 7% of all cardiac
defects.1 It is commonly associated with genetic syn-
dromes, particularly the 22q11.2 deletion syndrome
(22q11.2DS), which is present in 15% to 20% of patients
with TOF.2-5 The presence of a genetic syndrome has
been associated with increased morbidity and mortality in
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The Journal of Thoracic and Cardiovascular Surgidentified and may vary by genotype.6 For example, in-
creased mortality in the TOF subset with pulmonary atresia
and 22q11.2DS is seen irrespective of the degree of pulmo-
nary artery hypoplasia.7 In addition, noncardiac abnormal-
ities and malformation syndromes appear to be independent
risk factors for prolonged intubation, reintubation, and lon-
ger intensive care duration.8,9 Therefore, factors related to
genotype influence outcomes.
Risk stratification and counseling of patients with
22q11.2DS are of paramount importance in an era of prena-
tal diagnosis, advanced perinatal intensive care, and access
to subspecialized medicine. Understanding how genotype
affects outcomes might guide surgical decisions, periopera-
tive care, and pre- and postnatal counseling. In addition, this
knowledge may allow us to optimize management, conse-
quently leading to shorter hospital stays and improved car-
diovascular and neurocognitive outcomes.
We therefore sought to investigate the association of
22q11.2DS and perioperative outcomes in patients with
TOF.MATERIALS AND METHODS
Study Population
The study protocol was approved by the Institutional Review Board for
the Protection of Human Subjects at The Children’s Hospital of Philadel-
phia. We conducted a retrospective chart review study of patients whoery c October 2013
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
ND ¼ nondeleted
RV ¼ right ventricular
TOF ¼ tetralogy of Fallot
22q11.2DS ¼ 22q11.2 deletion syndrome
VSD ¼ ventricular septal defect
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phia between 1995 and 2006. We included patients who underwent com-
plete surgical reconstruction for TOF in a single operation, whether or
not it was preceded by placement of an aortopulmonary shunt. Patients
who underwent multiple stages of operations to reach complete repair
and those with genetic syndromes other than 22q11.2DS (eg, trisomy 21
and Alagille syndrome) were excluded. The hospital’s cardiothoracic sur-
gical database was used for subject ascertainment. Deletion status was con-
firmed for all patients. All patients with 22q11.2DS were included. All
nondeleted (ND) subjects with TOF and pulmonary valve atresia, absent
pulmonary valve leaflets, and associated common atrioventricular canal
were included. A subset of ND subjects with TOF and pulmonary valve ste-
nosis were randomly selected for comparative chart review based on
a power analysis that determined the sample size of TOF with pulmonary
stenosis needed for comparison with the 22q11.2DS group to detect differ-
ences in length of hospital stay. Surgical repair was categorized as (1) clo-
sure of ventricular septal defect (VSD) without need for relief of right
ventricular (RV) outflow tract obstruction; (2) VSD closure and relief of
RV outflow tract obstruction with placement of a patch without crossing
the pulmonary valve annulus (nontransannular patch); (3) VSD closure
and relief of RVoutflow tract obstruction with placement of a patch cross-
ing the pulmonary valve annulus (transannular patch); and (4) VSD closure
and placement of an RV to pulmonary artery conduit. Surgical era was di-
vided between early (1995-2000) and late (2001-2006) time periods.
Data Collection
Hospital medical records were reviewed to abstract the demographic
and relevant clinical variables from the index hospitalization. Intensive
carewas defined as the time between postoperative admission to the cardiac
intensive care unit to the time of discontinuation of mechanical ventilation,
removal of chest tubes and intracardiac lines, and discontinuation of vaso-
pressor medications. Subjects were grouped according to deletion status.
Anatomy was divided according to the pulmonary valve morphology: ste-
nosis, atresia, absent leaflets, and TOFwith complete common atrioventric-
ular canal defect. Major congenital anomalies (eg, cleft palate, intestinal
malrotation, tracheoesophageal fistula) were recorded. Operative and peri-
operative variables were collected, including cardiopulmonary bypass
(CPB) duration, cardiac and noncardiac events, discharge status (feeding
method), and number of medications. Examples of noncardiac events in-
cluded number of consulting services, infections requiring antibiotic treat-
ment, postoperative seizures confirmed by electroencephalogram, pleural
effusions requiring drainage, and tracheostomy. Examples of cardiac
events included pericardial effusions requiring pericardiocentesis, arrhyth-
mias requiring treatment, postoperative cardiac catheterizations, reopera-
tions, and cardiac arrest requiring resuscitation.
Statistical Analysis
Continuous variables were described as mean and standard deviation or
as median with interquartile ranges, where appropriate. Frequencies with
proportions were reported for categoric variables. The differences between
deleted and nondeleted groups were tested with theWilcoxon rank-sum test
for continuous variables and the Fisher exact test for categoric variables.The Journal of Thoracic and CaMultivariable regression models were used to assess the independent asso-
ciations between deletion status and length of intensive care, palliative pro-
cedure, and CPB time, adjusting for potential confounders, including birth
weight, age at repair, gestational age, and pulmonary valve status. P values
were 2-sided. All analyses were performed using SAS software version 9.2
(SAS Institute, Inc, Cary, NC).RESULTS
General Characteristics
The study included 208 subjects who met eligibility cri-
teria. A total of 164 ND patients were included for compar-
ison with 44 patients who had confirmed 22q11.2DS.
Analysis limited to survivors did not affect the comparisons
between the 2 groups; therefore, we included survivors and
nonsurvivors in the results. We found a predominance of
male subjects (60%) and whites (76%). Most were born
full term (79%) and were diagnosed postnatally (71%)
(Table 1). Pulmonary valve stenosis was the most common
presenting pulmonary valve status (63%). Ten percent of
subjects received an aortopulmonary shunt preceding com-
plete repair. Most subjects underwent surgery before 6
months of age, with 30% in the neonatal period. Relief of
RVoutflow tract obstruction was achieved with a transannu-
lar patch in 60% of subjects (Table 1).Comparisons According to Genotype
Subjects with and without 22q11.2DS were comparable
in terms of gender, race, weight, gestational age, timing
of diagnosis, presenting pulmonary valve status, and age
at surgical repair. In addition, there was no difference in fre-
quency of neonatal repairs (Table 1). A total of 22 aortopul-
monary shunts preceded complete repair, 12 performed in
the early surgical era and 10 in the late era (P ¼ .37).
Four patients died (3 ND and 1 22q11.2DS). There was
no difference in mortality between the 2 groups
(P ¼ 1.0). Most patients were discharged directly home,
with a minority being transferred to other facilities for con-
tinuation of care (Table 2).
The 22q11.2DS and ND groups were comparable in
terms of duration of time in the hospital preceding opera-
tion, length of stay after discharge from the intensive care
unit, duration of mechanical ventilation, number of cardiac
and noncardiac complications, and number of reoperations
(Table 2). There was a trend for longer overall length of hos-
pital stay in the 22q11.2DS group (P¼ .053). Feeding status
at discharge and the number of infections in the hospital
were comparable between the 2 groups (P ¼ .11 and .21,
respectively).
Major congenital anomalies were found in both groups,
without significant difference by deletion status. As ex-
pected for this patient population, those with 22q11.2DS
had more dysmorphic facies and more frequent ear, nose,
mouth, palate, hand, and skeletal anomalies. Other organ
systems were equally affected in the 2 subgroups.rdiovascular Surgery c Volume 146, Number 4 869
TABLE 1. Patient characteristics
Variable
ND
(N ¼ 164)
22q11.2DS
(N ¼ 44) P value
Gender
Female 65 (40) 20 (46) .30
Male 99 (60) 24 (54)
Race
White 128 (78) 30 (68) .18
African American 22 (13) 6 (14)
Other 14 (9) 8 (18)
Gestational age*
Full term 128 (78) 36 (82) .29
Premature 33 (20) 6 (14)
Unknown 3 (2) 2 (4)
Timing of TOF diagnosis
Prenatal 41 (25) 13 (30) .56
Postnatal 119 (73) 29 (66)
Unknown 4 (2) 2 (4)
Age at surgery, mo 3 (0.5-5.3) 3.9 (1.6-6.8) .13
Neonatal repair (<1 mo) 47 (29) 9 (20) .34
Weight on admission (kg) 5.1 (1.9) 5.0 (1.6) .91
Pulmonary valve anatomy
Stenosis 108 (66) 26 (59) .70
Atresia 42 (25) 14 (32)
Absent 13 (8) 4 (9)
Atrioventricular canal 1 (1) 0 (0)
Shunt-prey 13 (7) 9 (21) .03
Surgical repair
VSD closure alone 20 (12) 1 (2) .20
Nontransannular patch 13 (8) 5 (11)
Transannular patch 101 (62) 24 (55)
RV-PA conduit 30 (18) 14 (32)
Data are expressed as mean ( standard deviation), median (interquartile range), or
frequency (percentage). ND, Nondeleted; 22q11.2DS, 22q11.2 deletion syndrome;
VSD, ventricular septal defect; RV-PA, right ventricle to pulmonary artery; TOF,
tetralogy of Fallot. *Prematurity is defined as gestational age less than 37 weeks.
yShunt-pre refers to placement of aortopulmonary shunt before complete surgical
repair.
TABLE 2. Outcomes according to 22q11.2 deletion syndrome status
Variable
ND
(N ¼ 164)
22q11.2DS
(N ¼ 44) P value
Outcome
Death 3 (2) 1 (2) .9
Discharge 148 (90) 39 (89)
Other* 13 (8) 4 (9)
Length of stay, dy 6 (4-13) 9 (6-16) .053
Length of stay if discharged, d 6.0 (4-11) 9.0 (5-15) .02
Hospital stay>4 wk 9 (5) 2 (5) 1.00
Intensive care, d 4 (3-7) 6 (4-12) .007
CPB, min 74 ( 30) 84 ( 31) .02
Deep hypothermic circulatory
arrest, min
15.3 ( 20) 20.8 ( 23) .06
Ventilation, h 25.4 (10-74) 32 (23-90) .09
Resource use
No. of consultations
0 125 (76) 22 (50) .001
1 20 (12) 7 (16)
2 19 (12) 15 (34)
Complications
Infections 11 (7) 6 (14) .21
Pericardial effusion 7 (4) 1 (2) 1.00
Junctional ectopic tachycardia 13 (8) 1 (2) .31
Catheterizations 31 (19) 13 (30) .15
Reoperations 15 (9) 4 (9) .85
Extracorporeal membrane
oxygenation
1 (0.6) 1.00
Cardiac arrest 5 (3) 1 (2.3) 1.00
Discharge characteristicsz N ¼ 161 N ¼ 43
Feeding
Nasogastric þ oral 24 (15) 11 (26) .11
Oral 137 (85) 32 (74)
No. of medications 2 (1-3) 3 (2-5) .0001
Data are expressed as mean ( standard deviation), median (interquartile range), or
number (percentage). ND, Nondeleted; 22q11.2DS, 22q11.2 deletion syndrome;
CPB, cardiopulmonary bypass. *Discharged to another hospital or chronic care facil-
ity. yLength of stay for the whole cohort. zIncludes survivors only.
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Patients with 22q11.2DS more commonly received an aor-
topulmonary shunt preceding complete surgical repair (9/44
[21%] compared with 13/164 [7%] in the ND group,
P¼ .03). This association remained significant after adjust-
ing for pulmonary valve status, gestational age, birth
weight, admission weight, age at surgical repair, extracar-
diac malformations, and era of surgical repair. Moreover,
the patients with 22q11.2DS had longer duration of CPB
(84  31 minutes vs 74  30 minutes, P ¼ .02). This asso-
ciation persisted after adjusting for previous shunt place-
ment and presenting pulmonary valve status. Overall
length of intensive care was longer for the 22q11.2DS group
(6 days [4-12] vs 4 days [3-8] in the ND group, P ¼ .007)
(Table 2). CPB was a confounder of the association of dele-
tion status and length of intensive care, although CPB was
not an independent predictor of length of intensive care. Al-
though most of the ND group had no consultations by other870 The Journal of Thoracic and Cardiovascular Surgsubspecialties, 50% of the 22q11.2DS group had consulta-
tions, of whom 25% had more than 2 consultations during
the hospital stay (P ¼ .001). Finally, the 22q11.2DS group
was discharged with more medications compared with the
ND group (3 [2-5] vs 2 [1-3], P ¼ .001).
DISCUSSION
Our study identifies important differences in periopera-
tive outcomes between subjects with 22q11.2DS and ND
subjects with TOF. Patients with 22q11.2DS were observed
to have more palliative procedures, longer CPB, longer du-
ration of intensive care, and more resource use in terms of
consultations by other subspecialties. Potential causes for
increased intensive care in the 22q11.2DS population could
be their tendency toward airway difficulties and need for in-
creased respiratory support.10 However, mechanical venti-
lation was comparable in the 2 groups; thus, it is unlikely
that intensive care was prolonged on account of the durationery c October 2013
TABLE 3. Extracardiac malformations according to 22q11.2 deletion
syndrome status
ND
(N ¼ 164)
22q11.2DS
(N ¼ 44) P value
Dysmorphic facies 43 (26) 37 (84) <.001
Head 8 (5) 2 (5) .95
Eye 6 (4) 4 (9) .13
Ear 16 (10) 17 (39) <.001
Nose 8 (5) 17 (39) <.001
Mouth 6 (4) 10 (23) .001
Palate* 8 (5) 12 (27) <.001
Airwayy 7 (4) 4 (9) .23
Abdominalz 6 (4) 2 (4.5) .92
Renalx 6 (4) 2 (5) .98
Genitaljj 10 (6) 2 (5) .61
Skeletal{ 17 (10) 11 (25) .03
Hand 23 (14) 18 (41) <.001
Data are expressed as number (percent). ND, Nondeleted; 22q11.2DS, 22q11.2 dele-
tion syndrome. *Cleft lip/palate, submucous cleft, bifid uvula, high arched palate, and
velopharyngeal incompetence. yLaryngo-bronchio-tracheomalacia, tracheal stenosis,
subglottic stenosis, choanal stenosis or atresia, tracheal web, tracheoesophageal fis-
tula. zIntestinal malrotation, omphalocele, umbilical/inguinal hernia, pyloric steno-
sis, polysplenia. xHorseshoe, cystic, dysplastic, and single kidney; hydronephrosis;
ureteral abnormalities. jjAmbiguous genitalia, hypospadias, undescended testes, im-
perforate anus, anteriorly placed anus. {Hemi and butterfly vertebrae, fused ribs,
short limbs, scoliosis, winged scapula, sacral dimple, tethered cord.
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have contributed to longer intensive care duration. Of
note, patients with 22q11.2DS did not have more infections
than ND patients; therefore, infections were not likely to
contribute to the increased length of intensive care.
We found that patients with 22q11.2DS had longer du-
ration of CPB. Although not substantially different clini-
cally, this difference could in itself be associated with
a longer duration of intensive care because of a greater
systemic inflammatory response and resultant postopera-
tive edema and end-organ dysfunction. Allan and
colleagues11 found a positive correlation between inter-
leukin production and duration of CPB, longer intubation
times, and intensive care stay. However, the reason that
deletion status is associated with longer CPB is unclear,
and the retrospective nature of our study did not allow
for its determination.
Effect of genotype on surgical outcome, specifically the
renin-angiotensin-aldosterone system genotype, has been
linked to other groups of congenital heart disease.12
Thus, 22q11.2DS could likewise contribute to surgical out-
come, given that 22q11.2DS can affect genes that are in-
volved not only in the septation of the conotruncus but
also in RV structure, thus perhaps contributing to RV func-
tion and adaptation to surgical stress.13,14 Alternatively,
22q11.2DS might contribute to postoperative RV
restrictive physiology in TOF.15
Placement of an aortopulmonary shunt was more com-
monly performed in patients with 22q11.2DS, indepen-
dently of gestational age, pulmonary valve status, age at
surgical repair, and extracardiac malformations. Once
again, the retrospective nature of our study limits our ability
to discern specific factors that resulted in this management
plan. Moreover, it was not possible to ascertain from chart
review whether deletion status was known to the caretakers
before the surgical planning. Therefore, the knowledge of
deletion status may have affected the decision to perform
a shunt. Additional malformations might influence surgical
planning, as suggested by Michielon and colleagues.16
However, in our study the 22q11.2DS population did not
have more major anomalies than the ND subset, and thus
the difference in management strategy cannot be ascribed
to the presence of noncardiac anomalies. Although place-
ment of an aortopulmonary shunt does not seem to affect
survival after complete repair for TOF, it may increase the
risk for pulmonary artery distortion, which has the potential
to prolong perioperative recovery and hospitalization.17
Thus, a prior aortopulmonary shunt indirectly has the poten-
tial to add morbidity and increase costs.18,19
A prolonged hospitalization and longer period of intensive
care support in patients with 22q11.2DS may have signifi-
cant clinical implications. As a result of the deletion, chil-
dren with 22q11.2DS already have developmental delays,
hypotonia, and speech problems that seem to be independentThe Journal of Thoracic and Caof the cardiac disease.20 Evidence also suggests that the
length of the postoperative hospitalization for congenital
heart disease affects later neurodevelopment outcomes inde-
pendently of genetic syndromes and other factors, such as
demographic and socioeconomic status, perioperative com-
plications, and CPB times.21,22 Such evidence stresses the
need for focused management, especially in patients with
genetic syndromes, to accomplish a shorter hospital stay,
and thereby optimize neurocognitive outcomes.
Major extracardiac anomalies were present in both
groups, and significant differences were found in organs
that are typically involved with greater frequency in patients
with 22q11.2DS: anomalies of the ears, nose, mouth, palate,
and hand, most of which describe minor facial features
rather than major anomalies expected to confer a clinical
difference. We also found skeletal anomalies to be more
common in the 22q11.2DS group (Table 3). Other studies
found 22q11.2DS and ND subjects to be comparable in
terms of major organ system anomalies, such as airway, gas-
trointestinal, genital, renal, and central nervous system.23,24
Therefore, although dysmorphisms are common in patients
with 22q11.2DS, major extracardiac malformations were
not more common in the TOF group when compared with
those without 22q11.2DS.
Our study also describes important similarities between
patients with TOF with and without 22q11.2DS. We found
that overall patient characteristics, presenting anatomy,
complications, reoperations, major congenital anomalies,
and survival were comparable between the 2 groups. Of
note, feeding problems were not more common in therdiovascular Surgery c Volume 146, Number 4 871
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mon assumption that patients with 22q11.2DS have more
feeding difficulties. All of these findings are important
and highlight the fact that 22q11.2DS results in increased
morbidity, rather than mortality, in this particular patient
population.8,9,25 The same may not be true in the more
complicated cohort with major aortopulmonary collateral
arteries requiring staged repairs, as suggested by Mahle
and colleagues.7
Our results suggest that patients with 22q11.2DS require
more resource use as reflected by the increased number of
consulting services. These consultations likely provide ap-
propriate routing of the patient with 22q11.2DS to the var-
ious specialties needed in their follow-up.
Study Limitations
The retrospective nature of this study limits our ability to
further detail differences between the patients with and
without 22q11.2DS, including the ability to ascertain
whether the patient was recognized clinically to have Di-
George syndrome or whether deletion status was known
to the caretakers before surgical planning. Such knowledge
might have biased caretakers toward placement of an aorto-
pulmonary shunt preceding a complete repair in the
22q11.2DS group.
We opted not to examine echocardiographic variables
(eg, the size of the pulmonary arteries) because of the in-
consistency associated with retrospective data collection.
Nonetheless, we were able to study a large number of pa-
tients with TOF who underwent operation at a single in-
stitution. In addition, because we included only subjects
with a complete repair preceded or not by an aortopulmo-
nary shunt, we were able to study a relatively homoge-
neous population in terms of cardiac phenotype and
surgery. Therefore, these results likely apply to patients
with TOF with anatomy favorable for this type of surgical
approach.
CONCLUSIONS
This study examined a large group of patients with TOF
who underwent operation at a single institution and reports
outcomes in the subset undergoing complete surgical repair.
We found that although outcomes are comparable in many
respects, patients with TOF and 22q11.2DS are at risk for
longer postoperative recovery, suggesting that postopera-
tive management may need to be tailored to the patient
with 22q11.2DS. This finding is particularly important
given the evidence for worse cognitive outcomes associated
with longer hospital stays. Also noteworthy was the encour-
aging finding that the 22q11.2DS group had a similar sur-
vival as the ND group.
In the era of prenatal diagnosis and tailored patient care,
genetic stratification is important and should be considered
when counseling parents, planning surgical procedures, and872 The Journal of Thoracic and Cardiovascular Surgdetermining postoperative management strategies in pa-
tients with TOF. Future studies should target the periopera-
tive period to identify modifiable factors to improve
outcomes.
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